An exploration of medical professionals’ attitudes, perceived knowledge and concerns around medical cannabis in the United Kingdom
Research
Drug Science publishes peer reviewed research, reports, and articles to provide clear, evidence-based information without political or commercial interference.
Compliance in the laboratory: Navigating the Controlled Substances Act and Federal Analogue Act in scientific research
Allaying the fears: Midomafetamine with therapy is a medicine
3,4-Methylenedioxymethamphetamine (MDMA) consumption in Aotearoa New Zealand: A quantitative survey exploration
Allaying the fears: MDMA with therapy is a medicine
In defence of the decriminalisation of drug possession in the UK
Childhood trauma, challenging experiences, and post traumatic growth in ayahuasca use
Participation in an indigenous Amazonian-led ayahuasca retreat associated with increases in nature relatedness – a pilot study
A history of the European Medical Society for Psycholytic Therapy (EPT) 1964–1974
Investigation of the household storage of medicines and disposal practices in Parklands sub-county in Nairobi, Kenya
Minorities’ diminished psychedelic returns: Cardio-metabolic health
Counting and accounting for drug-related deaths at UK music festivals 2017–2023: A commentary
Decrypting the cryptomarkets: Trends over a decade of the Dark Web drug trade
The impact of over the counter and prescription medication misuse on friends and family
From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia
Racial and religious motives for drug criminalization